Scientific Programme 2016

The plenary presentations and videos from the G-I-N 2016 Conference in Philadelphia can be viewed here.

Opening plenary – Individualizing Guidelines in an Era of Personalised Medicine

Douglas K Owens MD, PhD (USA) – How Do We Individualize Guidelines in an Era of Personalized Medicine?

Click here to view Dr Owens’ presentation

Fergus Macbeth MA, DM, FRCP, FRCR (UK) – Personalised Medicine – Bright Future or False Dawn

Click here to view Dr Macbeth’s presentation [link to Personalised Medicine no pics or notes]

Lelis B Vernon (USA) – Guideline Development: A patient’s Experience

Click here to view Ms Vernon’s presentation. 

To view the Opening Plenary Panel Discussion click here.

Plenary 1 – Translating Guidelines to Performance Measures in an Era of Accountability

Diane Watson, PhD (Australia) – Improving Transparency, Accountability, and Quality and Safety Standards in Australia

Click here to view Dr Watson’s presentation.

Kate Goodrich, MD (USA) – Quality Payment Programme

Click here to view Kate’s presentation.

Anke Bramesfeld, MD (Italy) – Translating Clinical Guidelines into Performance Measurements – The Challenge of Being Both Relevant and Feasible

Click here to view Anke’s presentation.

To view the Plenary 1 Panel Discussion click here.  

Plenary 2 – Incorporating Alternative Forms of Evidence into Guidelines

Jane Noyes, DPhil (UK) – Never Mind the Qualitative – Feel the Depth! Incorporating Qualitative Evidence on Intervention Feasibility, Acceptability and Implementation in Guideline Development

Click here to view Jane’s presentation. 

Martin Kohn, MD (USA) – Guidelines, Personalised Healthcare and Real World Data

Click here to view Dr Kohn’s presentation.

Teun Zuiderent-Jerak, (Sweden) – The Pitfalls and Promises of Appraising and Including Different (AID) Knowledge

Click here to view Dr Zuiderent-Jerak’s presentation.

To view the Plenary 2 Panel Discussion click here.

Plenary 3 – Innovative Efficiencies in Guideline Development, Maintenance, and Adaptation: A Look to the Future

Mark Baker, MD, PhD (UK) – Maintaining the Currency of a Large Guidelines Portfolio; Necessity is the Mother of Invention

Click here to view Mark’s presentation.

Paul Shekelle, MD, PhD (USA) – Keeping Guidelines Up to Date: Progress and Challenges

Click here to view Paul’s presentation.

Naohito Yamaguchi, MD (Japan) – Internet-Based Support for Guideline Development, Maintenance, and Adaptation in Japan; Current Situation and Future Direction

Click here to view Naohito’s presentation.

To view the Plenary 3 Panel Discussion click here.

Closing Plenary – Leveraging Technology to Promote Guideline Implementation

Lawrence Mbuagabaw, MD, PhD (Canada) – Mobile Applications to Support the Implementation of Guidelines

Click here to view Lawrence’s presentation.

Kevin Larsen, MD (USA) – Using Health IT to Improve Outcomes – A Federal Perspective (Presentation Not Available)

Click here to view Kevin’s presentation.

Per Vandvik, MD, PhD (Norway) – Digital and Trustworthy Evidence Ecosystem for Increased Value and Reduce Waste in Research and Health Care: Fact or Fiction?

Click here to view Per’s presentation.

To view the Closing Plenary Panel Discussion click here.

Panel 07: The Importance of Being Precise- how Specificity Matters to Guideline and Performance Measure Developers

Cross – National Use of Guideline Based Performance Measures

Ina Kopp and Monika Nothacker

Click here to view the slides